Target intelligence / Profile preview

Zinc finger SWIM domain-containing protein 8 (ZSWIM8)

Target
ZSWIM8
Molecular classification
E3 ubiquitin-protein ligase (Cullin-RING ligase type), SCF-like ubiquitin ligase complex substrate receptor, Protein with zinc finger SWIM domain
01

Overview

Zinc finger SWIM domain-containing protein 8 (ZSWIM8) is a substrate recognition component of a **Cullin-RING E3 ubiquitin ligase complex** that promotes **target-directed microRNA degradation (TDMD)**, a post-transcriptional gene-silencing regulatory process. ZSWIM8 binds Argonaute (AGO) proteins loaded with specific microRNAs extensively paired to targets, enabling ubiquitination and proteasomal degradation of AGO, which then exposes the microRNA for degradation[1][5][4][2]. ZSWIM8 also recognizes misfolded proteins such as ROBO3 and DAB1 for quality control during neural development, and is implicated in axon guidance, embryonic tissue development, and myogenic differentiation[1][3][4]. It contains a characteristic zinc finger SWIM domain, Cul2/VHL boxes, and is evolutionarily conserved from invertebrates to vertebrates[1][2]. No drugs currently target this protein, and it is not classified as a direct therapeutic target, but its biological roles are critical in normal development and disease pathogenesis.

Other names
KIAA09134832404P21RikPeladoDoradoZSWIM8Zswim8 (mouse ortholog; sometimes written in lowercase)
02

Mechanism of action

Not applicable/no known drugs

03

Biological functions

Target-directed microRNA degradation (TDMD), mediating degradation of microRNAs by facilitating the ubiquitination and degradation of Argonaute (AGO) proteinsProtein ubiquitination and subsequent proteasomal degradation of substrate proteinsRegulation of axon guidance via degradation of misfolded Robo receptorsRegulation of protein quality control, e.g., DAB1 degradationModulation of embryonic development (heart, lung, brain)Modulation of myogenic differentiation (muscle cell differentiation)
04

Disease associations

Developmental abnormalities (e.g., Acromelic Frontonasal Dysostosis)Potential roles in neural development defects (linked to axon guidance pathways)Modulation of antiviral response (Zika virus manipulation of STAT2 degradation)Possibly cancer, though evidence is indirect (cell viability/fitness screens)
05

Safety considerations

Not specifically reported as a safety concern; loss-of-function mutations are associated with severe developmental abnormalitiesZSWIM8 knockout is lethal in some model organisms, indicating essential developmental roles
06

Interacting drugs

None known or reported
07

Biomarkers

None established or reported

Beyond the preview

Go deeper on Zinc finger SWIM domain-containing protein 8 (ZSWIM8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger SWIM domain-containing protein 8 (ZSWIM8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call